rs587782931
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_004387.4(NKX2-5):c.809G>A(p.Cys270Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000573 in 1,605,184 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000061 ( 1 hom. )
Consequence
NKX2-5
NM_004387.4 missense
NM_004387.4 missense
Scores
2
11
6
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
NKX2-5 (HGNC:2488): (NK2 homeobox 5) This gene encodes a homeobox-containing transcription factor. This transcription factor functions in heart formation and development. Mutations in this gene cause atrial septal defect with atrioventricular conduction defect, and also tetralogy of Fallot, which are both heart malformation diseases. Mutations in this gene can also cause congenital hypothyroidism non-goitrous type 5, a non-autoimmune condition. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.33408087).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000606 (88/1452930) while in subpopulation MID AF= 0.00296 (17/5744). AF 95% confidence interval is 0.00189. There are 1 homozygotes in gnomad4_exome. There are 40 alleles in male gnomad4_exome subpopulation. Median coverage is 35. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NKX2-5 | NM_004387.4 | c.809G>A | p.Cys270Tyr | missense_variant | 2/2 | ENST00000329198.5 | NP_004378.1 | |
NKX2-5 | NM_001166176.2 | c.*608G>A | 3_prime_UTR_variant | 2/2 | NP_001159648.1 | |||
NKX2-5 | NM_001166175.2 | c.*762G>A | 3_prime_UTR_variant | 2/2 | NP_001159647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NKX2-5 | ENST00000329198.5 | c.809G>A | p.Cys270Tyr | missense_variant | 2/2 | 1 | NM_004387.4 | ENSP00000327758.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152254
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000915 AC: 21AN: 229386Hom.: 1 AF XY: 0.000111 AC XY: 14AN XY: 126652
GnomAD3 exomes
AF:
AC:
21
AN:
229386
Hom.:
AF XY:
AC XY:
14
AN XY:
126652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000606 AC: 88AN: 1452930Hom.: 1 Cov.: 35 AF XY: 0.0000554 AC XY: 40AN XY: 721772
GnomAD4 exome
AF:
AC:
88
AN:
1452930
Hom.:
Cov.:
35
AF XY:
AC XY:
40
AN XY:
721772
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372
GnomAD4 genome
AF:
AC:
4
AN:
152254
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
7
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 13, 2023 | Identified in a patient with Jervell and Lange-Nielsen syndrome (JLNS) and refractory epilepsy who is also homozygous for a pathogenic KCNQ1 variant (PMID: 29037160); Identified in a patient with DCM and sudden cardiac arrest (PMID: 30611920) and in two patients with Tetralogy of Fallot (ToF) and additonal features (PMID: 19948535); Identified in two siblings with congenital heart disease (CHD) who also harbored variants in other CHD-related genes (PMID: 25742962); the variant was present in the unaffected mother but was absent in a maternal uncle with a personal history of CHD; A published functional study suggests there is no difference in activity between the p.(C270Y) variant and wildtype (PMID: 19948535); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20725931, 34426522, 31824610, 32369864, 19948535, 30611920, 29037160, 25742962) - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | NKX2-5: PS4:Moderate, PM6:Supporting, PP3 - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Dept of Medical Biology, Uskudar University | Jan 08, 2024 | Criteria: PP2, PP3, BS2 - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The p.C270Y variant (also known as c.809G>A), located in coding exon 2 of the NKX2-5 gene, results from a G to A substitution at nucleotide position 809. The cysteine at codon 270 is replaced by tyrosine, an amino acid with highly dissimilar properties. This variant has been reported in individuals with a variety of phenotypes, including congenital heart defects, Jervell Lange-Nielsen, and dilated cardiomyopathy, as well as in unaffected family members; some cases also had additional cardiac variants detected (Rauch R et al. J. Med. Genet., 2010 May;47:321-31; Abou Hassan OK et al. Sci Rep, 2015 Mar;5:8848; Uysal F et al. BMC Med. Genet., 2017 10;18:114; Monaco I et al. J Electrocardiol, 2018 Dec;53:40-43). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Atrial septal defect 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | - - |
Single ventricle;CN219571:small Atrial septal defect Benign:1
Likely benign, no assertion criteria provided | research | Nemer Genomics and Translation Biomedicine Lab, American University of Beirut | Jan 01, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
B
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at